Pediatric Specialists of Virginia

Fairfax, Virginia 22031

1 studies enrolling now · 7 studies all time

What they study most

Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Functional Constipation in Children Ages 6-17 Years, Indeterminate Colitis, Inflammatory Bowel Diseases, Pediatric Crohn's Disease, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — Recruiting now
• A Long-term Extension Study of Ustekinumab in Pediatric Participants — Running, not enrolling
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Completed
• Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy — Completed
• Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease — Completed
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) — Completed